NFE2L2 and acute myeloid leukemia: Nrf2 is a master regulator of oxidative stress regulating expression of genes involved in neutralising ROS and aberrant Nrf2 activity has been shown to contribute to development, progression and chemotherapy resistance in multiple cancers including AML [31, 32].